Resona Asset Management Co. Ltd. grew its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 4.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 469,660 shares of the conglomerate’s stock after buying an additional 21,610 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Danaher were worth $88,319,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the stock. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the 4th quarter valued at about $26,000. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter valued at about $26,000. Hilton Head Capital Partners LLC purchased a new position in Danaher in the 4th quarter valued at about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd lifted its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Argus reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Guggenheim decreased their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Finally, Evercore reiterated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $233.52.
Danaher Stock Down 1.7%
DHR opened at $190.90 on Thursday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The business has a 50-day moving average of $179.85 and a two-hundred day moving average of $199.68. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market capitalization of $135.11 billion, a price-to-earnings ratio of 36.92, a price-to-earnings-growth ratio of 2.48 and a beta of 0.79.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the firm posted $1.88 EPS. The company’s revenue was up 3.7% on a year-over-year basis. On average, research analysts expect that Danaher Corporation will post 8.44 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
